Summary
Doctors and patients are excited about the possible breakthrough, but some analysts believe there’s too much hype.
Moderna’s personalized mRNA shot could reshape the fight against skin cancer — but it may also be overhyped
Source & full coverage: this summary is aggregated from MarketWatch, the original publisher. Read the complete report for full context, data and quotes.
Read the original report at MarketWatch →
